Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR

24.69  +0.08 (+0.3%)

Fundamental Rating

3

Overall 1BAYN gets a fundamental rating of 3 out of 10. We evaluated 1BAYN against 53 industry peers in the Pharmaceuticals industry. 1BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

1BAYN had positive earnings in the past year.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.98%, 1BAYN is doing worse than 67.92% of the companies in the same industry.
1BAYN has a Return On Equity of -10.03%. This is in the lower half of the industry: 1BAYN underperforms 67.92% of its industry peers.
Industry RankSector Rank
ROA -2.98%
ROE -10.03%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of 1BAYN has declined.
1BAYN has a Gross Margin of 53.99%. This is in the lower half of the industry: 1BAYN underperforms 73.58% of its industry peers.
1BAYN's Gross Margin has declined in the last couple of years.
1BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.99%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
1BAYN has about the same amout of shares outstanding than it did 5 years ago.
1BAYN has a better debt/assets ratio than last year.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1BAYN has an Altman-Z score of 0.82. This is a bad value and indicates that 1BAYN is not financially healthy and even has some risk of bankruptcy.
1BAYN has a worse Altman-Z score (0.82) than 64.15% of its industry peers.
The Debt to FCF ratio of 1BAYN is 6.81, which is on the high side as it means it would take 1BAYN, 6.81 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.81, 1BAYN is in line with its industry, outperforming 45.28% of the companies in the same industry.
1BAYN has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of 1BAYN (1.08) is worse than 60.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.81
Altman-Z 0.82
ROIC/WACCN/A
WACC6.22%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.25 indicates that 1BAYN should not have too much problems paying its short term obligations.
The Current ratio of 1BAYN (1.25) is worse than 73.58% of its industry peers.
1BAYN has a Quick Ratio of 1.25. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
1BAYN's Quick ratio of 0.79 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 67.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.79
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.72%.
1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
1BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -0.92%.
1BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-24.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-11.7%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-0.2%

3.2 Future

The Earnings Per Share is expected to grow by 1.19% on average over the next years.
1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.18% yearly.
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y1.19%
Revenue Next Year-0.13%
Revenue Next 2Y0.7%
Revenue Next 3Y1.06%
Revenue Next 5Y1.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.23, the valuation of 1BAYN can be described as very cheap.
96.23% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
1BAYN is valuated cheaply when we compare the Price/Earnings ratio to 26.20, which is the current average of the S&P500 Index.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 5.00.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 98.11% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1BAYN to the average of the S&P500 Index (22.13), we can say 1BAYN is valued rather cheaply.
Industry RankSector Rank
PE 5.23
Fwd PE 5
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

79.25% of the companies in the same industry are more expensive than 1BAYN, based on the Enterprise Value to EBITDA ratio.
1BAYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.2
EV/EBITDA 7.1
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.15%
EPS Next 3Y1.51%

More info and screens

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.46%, 1BAYN is not a good candidate for dividend investing.
1BAYN's Dividend Yield is slightly below the industry average, which is at 3.05.
With a Dividend Yield of 0.46, 1BAYN pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.46%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.03%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (5/29/2025, 7:00:00 PM)

24.69

+0.08 (+0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners47.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.26B
Analysts67.59
Price Target27.49 (11.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.46%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-4.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.63%
Min EPS beat(2)1.86%
Max EPS beat(2)3.41%
EPS beat(4)3
Avg EPS beat(4)-1.9%
Min EPS beat(4)-17.26%
Max EPS beat(4)4.42%
EPS beat(8)5
Avg EPS beat(8)-2.92%
EPS beat(12)8
Avg EPS beat(12)-2.14%
EPS beat(16)12
Avg EPS beat(16)1.92%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)4
Avg Revenue beat(12)-2.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.66%
PT rev (1m)-0.45%
PT rev (3m)-0.65%
EPS NQ rev (1m)-10.26%
EPS NQ rev (3m)6.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.05%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-4.38%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 5.23
Fwd PE 5
P/S 0.52
P/FCF 4.2
P/OCF 2.85
P/B 0.75
P/tB N/A
EV/EBITDA 7.1
EPS(TTM)4.72
EY19.12%
EPS(NY)4.93
Fwd EY19.99%
FCF(TTM)5.88
FCFY23.83%
OCF(TTM)8.65
OCFY35.05%
SpS47.41
BVpS33.03
TBVpS-18.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.98%
ROE -10.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.99%
FCFM 12.41%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.81
Debt/EBITDA 4.37
Cap/Depr 30.76%
Cap/Sales 5.84%
Interest Coverage N/A
Cash Conversion 106.2%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.79
Altman-Z 0.82
F-Score3
WACC6.22%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-11.7%
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y1.19%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-0.2%
Revenue Next Year-0.13%
Revenue Next 2Y0.7%
Revenue Next 3Y1.06%
Revenue Next 5Y1.18%
EBIT growth 1Y-214.77%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.3%
EBIT Next 3Y21.17%
EBIT Next 5Y9.38%
FCF growth 1Y380.55%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y99.13%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%